BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

656 related articles for article (PubMed ID: 16898902)

  • 21. Long-term follow-up of patients with early-stage cutaneous T-cell lymphoma who achieved complete remission with psoralen plus UV-A monotherapy.
    Querfeld C; Rosen ST; Kuzel TM; Kirby KA; Roenigk HH; Prinz BM; Guitart J
    Arch Dermatol; 2005 Mar; 141(3):305-11. PubMed ID: 15781671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. "High-dose" UVA1 therapy of widespread plaque-type, nodular, and erythrodermic mycosis fungoides.
    Zane C; Leali C; Airò P; De Panfilis G; Pinton PC
    J Am Acad Dermatol; 2001 Apr; 44(4):629-33. PubMed ID: 11260537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Long term results of total skin electron beam therapy (TSEBT) in the treatment of mycosis fungoides].
    Hagedorn M; Hasche E; Kober B; Sander CA
    Hautarzt; 2003 Mar; 54(3):256-64. PubMed ID: 12634995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of mycosis fungoides using a 308-nm excimer laser: two case studies.
    Meisenheimer JL
    Dermatol Online J; 2006 Dec; 12(7):11. PubMed ID: 17459297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. UVA/UVB phototherapy for atopic dermatitis revisited.
    Valkova S; Velkova A
    J Dermatolog Treat; 2004 Jul; 15(4):239-44. PubMed ID: 15764039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A chart review of patients with early stage mycosis fungoides treated with psoralen plus UVA (PUVA).
    Soung J; Muigai W; Amin N; Stern DK; Lebwohl MG
    J Drugs Dermatol; 2005; 4(3):290-4. PubMed ID: 15898283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Broad band UVA: a possible reliable alternative to PUVA in the treatment of early-stage mycosis fungoides.
    El Mofty M; Ramadan S; Fawzy MM; Hegazy RA; Sayed S
    Photodermatol Photoimmunol Photomed; 2012 Oct; 28(5):274-7. PubMed ID: 22971197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Total skin electron irradiation therapy in mycosis fungoides using high-dose rate mode: a preliminary experience.
    Parida DK; Verma KK; Chander S; Joshi RC; Rath GK
    Int J Dermatol; 2005 Oct; 44(10):828-30. PubMed ID: 16207183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Narrow band UVB (311 nm), psoralen UVB (311 nm) and PUVA therapy in the treatment of early-stage mycosis fungoides: a right-left comparative study.
    El-Mofty M; El-Darouty M; Salonas M; Bosseila M; Sobeih S; Leheta T; Nada H; Tawdy A; Amin I; El-Enany G
    Photodermatol Photoimmunol Photomed; 2005 Dec; 21(6):281-6. PubMed ID: 16313238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psoralen plus UVA vs. UVB-311 nm for the treatment of lichen planus.
    Wackernagel A; Legat FJ; Hofer A; Quehenberger F; Kerl H; Wolf P
    Photodermatol Photoimmunol Photomed; 2007 Feb; 23(1):15-9. PubMed ID: 17254030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Local narrowband UVB phototherapy vs. local PUVA in the treatment of chronic hand eczema.
    Sezer E; Etikan I
    Photodermatol Photoimmunol Photomed; 2007 Feb; 23(1):10-4. PubMed ID: 17254029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A retrospective, descriptive study of patients with Mycosis fungoides treated by phototherapy (oral PUVA, NB-UVB) with a twice-weekly regimen at the Institute of Dermatology, Bangkok, Thailand, with an experiential timeline of 13 years.
    Pattamadilok B; Poomputsar T
    Photodermatol Photoimmunol Photomed; 2021 Jan; 37(1):49-55. PubMed ID: 32964521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Photochemotherapy for mycosis fungoides.
    Roenigk HH
    Arch Dermatol; 1977 Aug; 113(8):1047-51. PubMed ID: 889332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Narrowband UVB (311 nm, TL01) phototherapy for pityriasis lichenoides.
    Aydogan K; Saricaoglu H; Turan H
    Photodermatol Photoimmunol Photomed; 2008 Jun; 24(3):128-33. PubMed ID: 18477131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plaque stage mycosis fungoides treated with bexarotene at low dosage and UVB-NB.
    D'Acunto C; Gurioli C; Neri I
    J Dermatolog Treat; 2010 Jan; 21(1):45-8. PubMed ID: 19603308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Total cutaneous electron beam therapy of mycosis fungoides].
    Le Bourgeois JP; Levy E; Haddad E; Marinello G; Geara F; Pavlovitch JM
    Ann Dermatol Venereol; 1989; 116(3):213-7. PubMed ID: 2662874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized double-blind trial of the treatment of chronic plaque psoriasis: efficacy of psoralen-UV-A therapy vs narrowband UV-B therapy.
    Yones SS; Palmer RA; Garibaldinos TT; Hawk JL
    Arch Dermatol; 2006 Jul; 142(7):836-42. PubMed ID: 16847198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phototherapy for mycosis fungoides.
    Dogra S; Mahajan R
    Indian J Dermatol Venereol Leprol; 2015; 81(2):124-35. PubMed ID: 25751327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Narrowband UVB and psoralen-UVA in the treatment of early-stage mycosis fungoides: a retrospective study.
    Diederen PV; van Weelden H; Sanders CJ; Toonstra J; van Vloten WA
    J Am Acad Dermatol; 2003 Feb; 48(2):215-9. PubMed ID: 12582391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.